Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot study

BACKGROUND & OBJECTIVES: Vaccination against SARS-CoV-2 is a recommendation from the World Health Organization as the foremost preference in the current situation to control the COVID-19 pandemic. BBV152 is one of the approved vaccines against SARS-CoV-2 in India. In this study, we determined SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Nathella Pavan, Padmapriyadarsini, C., Uma Devi, K. R., Banurekha, V. V., Nancy, Arul, Girish Kumar, C. P., Murhekar, Manoj V., Gupta, Nivedita, Panda, Samiran, Babu, Subash, Bhargava, Balram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555618/
https://www.ncbi.nlm.nih.gov/pubmed/34528524
http://dx.doi.org/10.4103/ijmr.IJMR_2066_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555618/
https://www.ncbi.nlm.nih.gov/pubmed/34528524
http://dx.doi.org/10.4103/ijmr.IJMR_2066_21

Ejemplares similares